AKT1 and lip and oral cavity carcinoma: In previous studies, we used mTOR-specific and dual-targeted PI3K/AKT inhibitors in oral cancer cell lines and found that blocking PI3K/mTOR increased the radiation sensitivity of oral cancer cells and reversed radiation resistance in a resistant strain (OML1-R) [9,10,11,12].